News Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Real-time Estimate Cboe BZX Other stock markets 12:45:51 2024-05-07 pm EDT			5-day change	1st Jan Change
411.4 ^USD	+2.20%		+4.57%	+0.95%

02:12pm	FOMO is Back
01:53pm	ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FOMO is Back	08:12am
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...	07:53am
Leerink Partners Adjusts Vertex Pharmaceuticals' Price Target to $529 From $511	06:31am	MT
Stifel Adjusts Vertex Pharmaceuticals' Price Target to $420 From $430	06:30am	MT
Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $456 From $450, Keeps Overweight Rating	05:46am	MT
Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $402 From $413, Keeps Equalweight Rating	05:46am	MT
RBC Adjusts Price Target on Vertex Pharmaceuticals to $424 From $417, Keeps Sector Perform Rating	05:42am	MT
Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $577 From $574, Keeps Buy Rating	05:42am	MT
Bernstein Adjusts Price Target on Vertex Pharmaceuticals to $458 From $450, Keeps Market Perform Rating	05:42am	MT
Vertex Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase	May. 06	MT
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	May. 06	DJ
Transcript : Vertex Pharmaceuticals Incorporated, Q1 2024 Earnings Call, May 06, 2024	May. 06
Vertex: Q1 Earnings Snapshot	May. 06	AQ
Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 EPS $4.76, vs. Street Est of $4.06	May. 06	MT
Vertex Pharmaceuticals Reiterates FY 2024 Total Product Revenue Guidance of $10.55-$10.75 Billion	May. 06	MT
Vertex Reports First Quarter 2024 Financial Results	May. 06	BU
Vertex Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06	CI
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments	May. 06	RE
Vertex Pharmaceuticals Incorporated Re-Iterates Earnings Guidance for the Full Year 2024	May. 06	CI
Equity Markets Higher as Traders Parse Fed Official's Remarks	May. 06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am EST